RESULTS OF TREATMENT OF PATIENTS WITH LOCALLY ADVANCED AND METASTATIC NON-SQUAMOUS CELL NON-SMALL-CELL LUNG CARCINOMA WITH PEMETREXED (BY OWN EXPERIENCE)

Lung cancer is one of the most common malignant tumors. As over 70 % of patients at diagnosis have locally advanced or generalized process, the majority of patients receive drug treatment only. We evaluated effectiveness and toxicity of pemetrexed (Alimta) in 24 patients with locally advanced and me...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: L. Yu. Vladimirova, A. E. Storozhakova, S. N. Kabanov, E. A. Kalabanova
Médium: Artigo
Jazyk:Russo
Vydáno: Tomsk National Research Medical Center of the Russian Academy of Sciences 2016-04-01
Edice:Sibirskij Onkologičeskij Žurnal
Témata:
non-small-cell lung cancer, adenocarcinoma of the lung, egfr mutation, chemotherapy, pemetrexed
On-line přístup:https://www.siboncoj.ru/jour/article/view/305
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky